Urgent Requirements at Medreich Limited, Bangalore for AR&D / FR&D - PHARMA WISDOM

Pharma, Life Science, Healthcare, Engineering Job Updates

Recent Updates

Tuesday, 3 December 2019

Urgent Requirements at Medreich Limited, Bangalore for AR&D / FR&D


Urgent Requirements at Medreich Limited Bangalore (AR & D & FR&D)
1.)    Department - Analytical Research & Development (AR&D) Formulation R&D. (method development, method validation, routine analysis and stability)
Qualification: M Pharma (Pharmaceutical Analysis) / M.Sc / PhD Chemistry/Analysis
Required Experienced 2 to 8 Years.
Job Profile: -
Candidate should have experience in Method development, Method validation of different pharmaceutical dosage forms.
Hands on experience/ knowledge in handling Analytical work related to DS and DPs in different phases with a proven track record (having worked with Global partners/ International exposure).
Hands on experience in Chromatography (HPLC, UPLC, HSGC), Spectroscopy (FTIR, UV), dissolution apparatus and Particle size measurements.
KEY Skills: HPLC Method Validation, UV, Dissolution, Apparatus UPLC Method Development FTIR. & RS.
2.) Department - Formulation Development (FR&D) Formulation R&D.
Qualification: M Pharma (Pharmaceutics) / Ph.D
Required Experienced 2 to 8 Years
Job Profile: -
Carrying out the Literature search on APIs, patents, excipients, technologies for the development of Solids (Tablets: IR, DR & ER dosage forms & Capsules: Powder and Pellets filled).
Should independently carry out the Formulation R&D and scale up activities. 
Experience in handling equipments like RMG, Fluid bed driers & Granulators, size reduction mills, Blenders, compression, coating & capsule filling machines.
Note- Please forward this message to other Pharma groups as well Pharma friends
Can send their resumes to sekhar.s@medreich.com/ teresia.t@medreich.com
Regards
HR Team Medreich Limited

Join for Regular Job Updates in Whats App & Telegram...


Thank You for Visiting
More Updates Visit daily @ www.pharmawisdom.co.in

No comments:

Post a comment